Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Presentations: 10
- Moderators:Lubos Petruzelka
- Coordinates: 8/08/2022, 11:00 - 12:00, Hall C7
-
+
OA07.01 - Session Introduction
11:00 - 11:01 | Author(s): Lubos Petruzelka
- Abstract
Loading... -
+
OA07.02 - Session Introduction
11:01 - 11:02 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA07.03 - Association Between Genetic Variation in the ATP-binding Cassette Transporter ABCC10 and nab-PTX Treatment in Japanese Cohort
11:02 - 11:12 | Author(s): Minoru Horiuchi
- Abstract
Loading... -
+
OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet
11:12 - 11:22 | Author(s): Stephen V. Liu
- Abstract
Loading... -
+
OA07.05 - Gemcitabine Plus Platinum Chemotherapy Re-challenge in Metastatic Pulmonary Lymphoepithelioma-like Carcinoma
11:22 - 11:32 | Author(s): Gavin Tin Chun Cheung
- Abstract
Loading... -
+
Session Moderator
11:22 - 11:32 | Author(s): Lubos Petruzelka
- Abstract
Loading... -
+
Session Moderator
11:22 - 11:32 | Author(s): Pilar Garrido
- Abstract
Loading... -
+
OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
11:32 - 11:42 | Author(s): Edouard Auclin
- Abstract
Loading... -
+
OA07.07 - Discussant
11:42 - 11:52 | Author(s): Navneet Singh
- Abstract
Loading... -
+
OA07.08 - Live Q&A
11:52 - 12:00
- Abstract
Loading...